List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 866 studies with search of:   "Merck" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain
Condition: Postoperative Pain
Interventions: Drug: MK0966, rofecoxib;   Drug: Comparator: valdecoxib
2 Recruiting Lipid Efficacy and Safety in Patients With Mixed Hyperlipidemia
Condition: Mixed Hyperlipemia
Interventions: Drug: MK0524B;   Drug: Atorvastatin
3 Recruiting Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast
Condition: Asthma
Interventions: Drug: montelukast sodium;   Drug: Comparator: placebo comparator
4 Recruiting Dose Range Finding Study of MK0941 in Patients With Type 2 Diabetes on Insulin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Comparator: MK0941;   Drug: Comparator: Placebo
5 Terminated An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: vorinostat;   Drug: Comparator: bexarotene
6 Active, not recruiting C-PHONE Study
Condition: Chemotherapy Induced Nausea and Vomiting
Intervention: Behavioral: Disease Management Assessment
7 Completed A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol
Condition: Cholesterol
Interventions: Drug: ezetimibe;   Drug: Comparator: Placebo (unspecified);   Drug: simvastatin
8 Recruiting A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK1006;   Drug: Comparator: Placebo
9 Completed MK0524 Asthma POC Study
Condition: Asthma
Interventions: Drug: Comparator: MK0524 + placebo;   Drug: Comparator: MK0524 + montelukast;   Drug: Comparator: placebo + montelukast;   Drug: Comparator: Placebo
10 Completed Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: MK0431, sitagliptin phosphate / Duration of Treatment: 18 weeks
11 Recruiting Vorinostat (MK0683, SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma;   Lung Cancer
Interventions: Drug: Suberoylanilide Hydroxamic Acid (SAHA);   Drug: Placebo (unspecified)
12 Completed A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)
Conditions: Breast Cancer;   Metastatic Bone Disease
Interventions: Drug: Odanacatib;   Drug: Comparator: zoledronic acid;   Drug: Comparator: Placebo (unspecified);   Drug: Comparator: Placebo (unspecified)
13 Completed A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults
Condition: Intra-Abdominal Infection
Interventions: Drug: Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks;   Drug: MK0826, /Duration of Treatment : 8 Weeks;   Drug: Comparator: metronidazole / Duration of Treatment: 8 Weeks
14 Recruiting MK4827 in Patients With Advanced Solid Tumors and BRCA Mutant Ovarian Cancer
Conditions: Solid Tumors and Ovarian Neoplasms;   Ovarian Neoplasms
Intervention: Drug: Comparator: MK4827 (PARP inhibitor)
15 Completed Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis
Condition: Osteoarthritis
Interventions: Drug: MK0663, etoricoxib;   Drug: Comparator: Diclofenac sodium
16 Terminated Vytorin Treating Uncontrolled Lipids (VyTUL) Study
Conditions: Cardiovascular Diseases;   Diabetes Mellitus
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks;   Drug: Comparator: atorvastatin / Duration of Treatment: 6 Weeks
17 Active, not recruiting MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen - Study A
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: Comparator : lopinavir (+) ritonavir;   Drug: Comparator: placebo (unspecified);   Drug: Comparator: placebo (unspecified)
18 Withdrawn A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension
Condition: Hypertension
Interventions: Drug: hydrochlorothiazide (+) losartan potassium;   Drug: losartan potassium;   Drug: Comparator: losartan potassium;   Drug: Comparator: Placebo (unspecified);   Drug: Comparator: Placebo (unspecified)
19 Completed MK0686 in Postsurgery Dental Pain
Condition: Pain, Postoperative
Intervention: Drug: MK0686
20 Recruiting Dose Escalation Trial of MK0646 in Advanced Solid Tumors and Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: MK0646

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options